Compare InMode Ltd (INMD) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs Neurocrine Biosciences Inc — how do they compare? InMode Ltd trades at $15.16 (market cap $872.08M), while Neurocrine Biosciences Inc trades at $157.76 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 18.9× InMode Ltd's market cap. Which is the better fit depends on your goals.
| INMD | NBIX | |
|---|---|---|
Market Cap | $872.08M | $16.46B |
Sector | Technology | Health |
52-Week High | $16.62 | $185.50 |
52-Week Low | $12.76 | $123.10 |
Enterprise Value | $375.42M | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
